• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Psoriasis biologics: a new era of choice.

作者信息

Mahil Satveer K, Smith Catherine H

机构信息

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.

St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.

出版信息

Lancet. 2019 Sep 7;394(10201):807-808. doi: 10.1016/S0140-6736(19)31772-6. Epub 2019 Aug 8.

DOI:10.1016/S0140-6736(19)31772-6
PMID:31402113
Abstract
摘要

相似文献

1
Psoriasis biologics: a new era of choice.银屑病生物制剂：选择的新时代。
Lancet. 2019 Sep 7;394(10201):807-808. doi: 10.1016/S0140-6736(19)31772-6. Epub 2019 Aug 8.
2
A new era in the management of psoriasis? The biologics: facts and controversies.银屑病治疗的新纪元？生物制剂：事实与争议。
Clin Dermatol. 2010 Jan-Feb;28(1):81-7. doi: 10.1016/j.clindermatol.2009.03.002.
3
Adherence to biologics in patients with psoriasis.银屑病患者对生物制剂的依从性。
Expert Rev Clin Immunol. 2018 Feb;14(2):155-161. doi: 10.1080/1744666X.2018.1427065. Epub 2018 Jan 16.
4
Psoriasis Is a Chronic Disease: Long Term Efficacy and Safety of New Biologics Is Important.银屑病是一种慢性疾病：新型生物制剂的长期疗效和安全性至关重要。
J Drugs Dermatol. 2017 Aug 1;16(8):s113-s114.
5
Safety of biologics in psoriasis.生物制剂治疗银屑病的安全性。
J Dermatol. 2018 Mar;45(3):279-286. doi: 10.1111/1346-8138.14096. Epub 2017 Dec 10.
6
Comment on "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics".关于“美国皮肤病学会（AAD）和美国国家银屑病基金会（NPF）联合发布的生物制剂治疗银屑病的护理指南”的评论
J Am Acad Dermatol. 2019 Aug;81(2):e45. doi: 10.1016/j.jaad.2019.03.068. Epub 2019 Mar 29.
7
Can the dose and dosing interval of biologics be optimized?生物制剂的剂量和给药间隔可以优化吗？
Br J Dermatol. 2020 Feb;182(2):264-266. doi: 10.1111/bjd.18457. Epub 2019 Sep 30.
8
Current biologic treatments for psoriasis.
Dermatol Nurs. 2009 Sep-Oct;21(5):259-66, 272; quiz 267.
9
From conventional to cutting edge: the new era of biologics in treatment of psoriasis.从传统到前沿：生物制剂治疗银屑病的新时代。
Dermatol Ther. 2008 Mar-Apr;21(2):131-41. doi: 10.1111/j.1529-8019.2008.00180.x.
10
Treatment of plaque psoriasis by sequential therapy with two 'biologics': the 'hit and run' approach, a report of two cases.
Br J Dermatol. 2006 Jul;155(1):211-3. doi: 10.1111/j.1365-2133.2006.07300.x.

引用本文的文献

1
Chinese herbal medicine (Guben Qushi Huayu formula) combined with Ixekizumab in reducing psoriasis vulgaris relapse: Protocol for a mixed-methods research study.中药（固本祛湿化瘀方）联合司库奇尤单抗减少寻常型银屑病复发：一项混合方法研究的方案
Front Pharmacol. 2025 Mar 21;16:1551001. doi: 10.3389/fphar.2025.1551001. eCollection 2025.
2
Biomarkers in Psoriasis: The Future of Personalised Treatment.银屑病中的生物标志物：个性化治疗的未来。
Indian J Dermatol. 2024 May-Jun;69(3):256-263. doi: 10.4103/ijd.ijd_167_24. Epub 2024 Jun 26.
3
Momordin Ic ameliorates psoriasis skin damage in mice via the IL-23/IL-17 axis.
苦瓜素 Ic 通过 IL-23/IL-17 轴改善小鼠银屑病皮肤损伤。
Arch Dermatol Res. 2024 Jul 15;316(7):474. doi: 10.1007/s00403-024-03023-y.
4
Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.在空腹和餐后状态下，中国健康受试者中阿普米司特片的药代动力学和生物等效性。
Drug Des Devel Ther. 2024 Jun 14;18:2273-2285. doi: 10.2147/DDDT.S461771. eCollection 2024.
5
LncRNA MIR181A2HG negatively regulates human keratinocytes proliferation by binding SRSF1.长链非编码RNA MIR181A2HG通过结合SRSF1负向调控人角质形成细胞的增殖。
Cytotechnology. 2024 Jun;76(3):313-327. doi: 10.1007/s10616-024-00621-6. Epub 2024 Mar 26.
6
Single-cell transcriptome analysis reveals keratinocyte subpopulations contributing to psoriasis in corneum and granular layer.单细胞转录组分析揭示了角质层和颗粒层中导致银屑病的角质形成细胞亚群。
Skin Res Technol. 2024 Feb;30(2):e13572. doi: 10.1111/srt.13572.
7
Non-pharmacological interventions for patients with psoriasis: a scoping review.非药物干预措施治疗银屑病患者：范围综述。
BMJ Open. 2023 Nov 24;13(11):e074752. doi: 10.1136/bmjopen-2023-074752.
8
Elevated serum IL-6 levels predict treatment interruption in patients with moderate to severe psoriasis: a 6-year real-world cohort study.血清 IL-6 水平升高可预测中重度银屑病患者的治疗中断：一项 6 年真实世界队列研究。
An Bras Dermatol. 2024 Jan-Feb;99(1):34-42. doi: 10.1016/j.abd.2023.03.002. Epub 2023 Aug 25.
9
Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.银屑病增加不良心血管结局风险：一项新的队列研究系统评价与荟萃分析
Front Cardiovasc Med. 2022 Mar 25;9:829709. doi: 10.3389/fcvm.2022.829709. eCollection 2022.
10
Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice Suppression of NF-κB and STAT3 Pathways.果皮多糖改善咪喹莫特诱导的小鼠银屑病样皮炎：对NF-κB和STAT3信号通路的抑制作用
Front Pharmacol. 2022 Jan 28;12:806844. doi: 10.3389/fphar.2021.806844. eCollection 2021.